HMO Mixture Production via Catalytic Hydrogenolysis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for manufacturing human milk oligosaccharides (HMOs) are costly and complex, making it difficult to produce a mixture that resembles the natural spectrum found in human milk, particularly for infant formula, and lack scalability without biotechnology.
Innovation Solution
A method involving catalytic hydrogenolysis of specific compounds to produce a mixture of HMOs, using a catalyst like palladium in a protic solvent, which regenerates hydroxyl groups and allows for the creation of a mixture with a profile similar to human breast milk, avoiding expensive biotechnology methods.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional chemical or enzymatic methods are used to manufacture HMOs, then individual HMOs can be produced, but the process is costly and cannot produce mixtures resembling the natural spectrum
Solution Approach 1:
The patent segments the HMO mixture into individual components that can be separately synthesized using conventional methods, then combines them in defined ratios to recreate the natural human milk HMO profile. This allows precise control over each HMO structure while enabling production of complex mixtures through systematic assembly of simpler parts.
2Stability of the object's composition
If biotechnology methods are used to produce HMO mixtures, then a natural-like profile can be achieved, but the process is complicated and expensive
Solution Approach 1:
The patent copies the natural human milk HMO profile by analyzing the composition and ratios of HMOs in human milk, then reproducing this profile through conventional chemical synthesis and mixture formulation. This creates a simplified model system that mimics the complex natural system without requiring biotechnology.
3Manufacturing precision
If individual HMO syntheses are performed to create mixtures, then specific HMOs can be produced with correct structure, but the process is costly and time-consuming
Solution Approach 1:
The patent performs preliminary synthesis of individual HMO components using conventional chemical or enzymatic methods, then prepares them in advance as standardized intermediates. These pre-synthesized components are then combined in defined ratios to create the final HMO mixture, eliminating the need for complex in-process synthesis during mixture production.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method enables the production of a mixture of HMOs with a profile similar to natural human milk, efficiently and cost-effectively, suitable for infant formula, enhancing immune system maturation and preventing infections.
Implementation Method 1
subjecting a mixture of at least two compounds selected from the group comprising compounds of general formulae 1 and 2 to catalytic hydrogenolysis to remove the R group
Data Source
AI summary
A method for the manufacture an infant formula or an infant nutritional product comprising mixture of human milk oligosaccharides is disclosed. The method involves the catalytic hydrogenolysis of compounds of the general formula 1 and 2 with particular oligosaccharide profiles.